FDA
-
-
-
-
-
-
-
FDA places clinical hold on Aardvark Therapeutics ARD-101 drug trials
-
-
-
-
-
-
-
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
-
-
-
-
-
-
-
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
-
-
-
-
-
-
329,907 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

